BATF3 and neoplasm: Furthermore, complete ablation or constitutive overexpression of transcription factors with tumour-suppressor functions (e.g. BLIMP1 (216)) or oncogenic potential (e.g. BATF3 (185, 217)) may be dangerous in modifying a cellular product.